Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (Sterol 14α-Demethylase) Doxycycline-Regulated Mutant and Screening of the Azole Sensitivity of Aspergillus fumigatus Isoenzymes CYP51A and CYP51B
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Aspergillus fumigatus sterol 14α-demethylase isoenzymes CYP51A and CYP51B were heterologously expressed in a Saccharomyces cerevisiae mutant (YUG37- erg11 ), wherein native ERG11/CYP51 expression is controlled using a doxycycline-regulatable promoter. When cultured in the presence of doxycycline, recombinant YUG37-p cyp51A and YUG37-p cyp51B yeasts were able to synthesize ergosterol and grow; a control strain harboring reverse-oriented cyp51A could not. YUG37-p cyp51A and YUG37-p cyp51B constructs showed identical sensitivity to itraconazole, posaconazole, clotrimazole, and voriconazole. Conversely, YUG37-p cyp51A withstood 16-fold-higher concentrations of fluconazole than YUG37-p cyp51B (8 and 0.5 μg ml −1 , respectively).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
Verweij, P. E., Snelders, E., Kema, G. H., Mellado, E., & Melchers, W. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70265-8 · Cited by 604
Mellado, E., Garcia-Effron, G., Alcázar-Fuoli, L., Melchers, W. J. G., Verweij, P. E., Cuenca-Estrella, M., & Rodríguez-Tudela, J. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01092-06 · Cited by 490 · cited 2×
“fumigatus appears to be the modification of CYP51A (5, 22, 25, 27, 28).”
BackgroundPossible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
Snelders, E., Huis in 't Veld, R. A. G., Rijs, A. J. M. M., Kema, G. H. J., Melchers, W. J. G., & Verweij, P. E. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00231-09 · Cited by 423 · cited 1×
“The emergence (4, 14, 30, 31, 32) and potential for spread (2) of azole-resistant Aspergillus (hereafter focusing on Aspergillus fumigatus) have highlighted the need to develop diagnostic tools (6, 9) and novel antifungal agents (15).”
BackgroundMellado, E., Diaz-Guerra, T. M., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.7.2431-2438.2001 · Cited by 307 · cited 1×
“fumigatus possesses two genes (cyp51A and cyp51B) encoding sterol 14 -demethylase-like enzymes (26), it has been reasoned that the relative importance of each for ergosterol biosynthesis and/or resistance phenotypes observed in the clinic might differ.”
BackgroundKelly, S. L., Lamb, D. C., Corran, A. J., Baldwin, B. C., & Kelly, D. E. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1272 · Cited by 296
Self-citationWhite, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1488 · Cited by 292
Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1120-1124.2003 · Cited by 281
Essential Gene Identification and Drug Target Prioritization in Aspergillus fumigatus
Hu, W., Sillaots, S., Lemieux, S., Davison, J., Kauffman, S., Breton, A., Linteau, A., Xin, C., Bowman, J., Becker, J., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030024 · Cited by 237 · cited 2×
“fumigatus despite neither member being essential individually (15).”
BackgroundWatson, P. F., Rose, M. E., Ellis, S. W., England, H., & Kelly, S. L. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91792-0 · Cited by 197 · cited 1×
“That the fungistatic sterol 14 -methyl ergosta 8,24(28)-dien-3 -6 -diol (17, 35) comprised 50% of gal/rafYM -cultured YUG37-pCTRL (Table 1) is consistent with the failure of the reverse-oriented cyp51A gene to complement and accounts for its inability to grow.”
BackgroundSelf-citationMartel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00303-10 · Cited by 165 · cited 1×
“The sterol composition of YUG37-pcyp51A, YUG37-pcyp51B, and YUG37-pCTRL constructs cultured using gal/rafYM medium (Table 1) was determined by gas chromatography mass spectrometry (GC-MS) as previously described (23).”
MethodSelf-citationKelly, S. L., Lamb, D. C., Loeffler, J., Einsele, H., & Kelly, D. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1136 · Cited by 116
Self-citationWarrilow, A. G. S., Melo, N., Martel, C. M., Parker, J. E., Nes, W. D., Kelly, S. L., & Kelly, D. E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00316-10 · Cited by 85
Self-citation
Research works printed but not linked: 24
- 10.1080/02681219080000411 · DOI
- 10.1128/AAC.01492-08 · DOI
- 10.1128/AEM.02158-09 · DOI
- 10.1128/AAC.41.6.1364 · DOI · Paper page
- 10.1111/j.1469-0691.2009.02929.x · DOI
- 10.1128/AAC.48.11.4405-4413.2004 · DOI · Paper page
- 10.2165/00003495-200868070-00008 · DOI
- 10.1128/JCM.02330-07 · DOI · Paper page
- 10.1023/A:1020342032302 · DOI
- 10.1128/AAC.00629-08 · DOI
- 10.1128/AAC.43.3.702 · DOI · Paper page
- 10.1080/13693780802545600 · DOI · Paper page
- 10.3201/eid1507.090043 · DOI · Paper page
- 10.1016/j.fgb.2008.08.010 · DOI
- Kelly, S. L., D. C. Lamb, and D. E. Kelly. 1999. Y132H substitution in Candida albicans sterol 14 alpha-demethylase confers fluconazole resistance by preventing binding to haem. FEMS Microbiol. Lett.180:171-175.
- 10.1074/jbc.272.9.5682 · DOI · Paper page
- 10.1016/S0378-1097(97)00172-9 · DOI
- 10.1128/AAC.47.2.577-581.2003 · DOI · Paper page
- 10.1128/AAC.00931-09 · DOI · Paper page
- 10.1080/13693780600902243 · DOI
- 10.1128/AAC.49.6.2536-2538.2005 · DOI · Paper page
- 10.1186/1471-2164-9-402 · DOI · Paper page
- Snelders, E., H. A. L. van der Lee, J. Kuijpers, A. Rijs, J. Varga, R. A. Samson, E. Mellado, A. R. T. Donders, W. J. G. Melchers, and P. E. Verweij. 2008. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med.5:1629-1637.
- 10.1007/s11745-008-3239-5 · DOI
Cited by
Denning, D. W., Park, S., Lass-Florl, C., Fraczek, M. G., Kirwan, M., Gore, R., Smith, J., Bueid, A., Moore, C. B., Bowyer, P., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir179 · Cited by 313
Dudakova, A., Spiess, B., Tangwattanachuleeporn, M., Sasse, C., Buchheidt, D., Weig, M., Groß, U., & Bader, O. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00095-16 · Cited by 113
Hull, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06253-11 · Cited by 113
“For complementation experiments (Table 2), medium to induce plasmid expression (gal/rafYM ) was prepared as previously described (24) using 2% galactose and 1% raffinose instead of glucose and with the addition of 5 g ml 1 (final concentration) doxycycline.”
MethodSelf-citationWarrilow, A. G., Nishimoto, A. T., Parker, J. E., Price, C. L., Flowers, S. A., Kelly, D. E., Rogers, P. D., & Kelly, S. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02586-18 · Cited by 60
Self-citationHollomon, D. (2017) · Pest Management Science · doi:10.1002/ps.4607 · Cited by 57
Metadata
- Authors
- Martel, C. M., Parker, J. E., Warrilow, A. G. S., Rolley, N. J., Kelly, S. L., & Kelly, D. E.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2010-11
- Volume
- 54
- Issue
- 11
- Pages
- 4920-4923
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2155943291
- Cited by
- 45
- References
- 12
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.